Artivion, Inc. Common Stock (NY:AORT)All News about Artivion, Inc. Common Stock![]() ![]()
This Analyst Says Artivion's Sell Off Seems Overdone After Trial Halt
September 26, 2022
Via Benzinga
![]()
Oppenheimer Maintains Outperform Rating for Artivion: Here's What You Need To Know
September 26, 2022
Via Benzinga
![]() ![]() ![]()
$100 Invested In This Stock 20 Years Ago Would Be Worth $600 Today
September 23, 2022
Via Benzinga
![]()
Artivion Stock Plunges Apixaban Vs. Warfarin Trial Setback, Reaffirms Annual Guidance
September 23, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|